These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19195622)

  • 41. Hepatitis C: a metabolic liver disease.
    Weinman SA; Belalcazar LM
    Gastroenterology; 2004 Mar; 126(3):917-9. PubMed ID: 14988846
    [No Abstract]   [Full Text] [Related]  

  • 42. The natural history of hepatitis C cirrhosis after liver transplantation.
    Firpi RJ; Clark V; Soldevila-Pico C; Morelli G; Cabrera R; Levy C; Machicao VI; Chaoru C; Nelson DR
    Liver Transpl; 2009 Sep; 15(9):1063-71. PubMed ID: 19718647
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pure alcoholic fatty liver and progression to cirrhosis or fibrosis.
    Ho AM; Contardi LH
    Lancet; 1995 Dec; 346(8989):1562-3. PubMed ID: 7491074
    [No Abstract]   [Full Text] [Related]  

  • 44. New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD).
    Ali R; Cusi K
    Ann Med; 2009; 41(4):265-78. PubMed ID: 19353360
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preface.
    Harrison SA
    Clin Liver Dis; 2009 Nov; 13(4):xiii-xiv. PubMed ID: 19818301
    [No Abstract]   [Full Text] [Related]  

  • 46. Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers.
    Edens MA; Kuipers F; Stolk RP
    Obes Rev; 2009 Jul; 10(4):412-9. PubMed ID: 19413701
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glucose abnormalities in non-alcoholic fatty liver disease and chronic hepatitis C virus infection: the role of iron overload.
    Lecube A; Hernández C; Simó R
    Diabetes Metab Res Rev; 2009 Jul; 25(5):403-10. PubMed ID: 19444865
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictive factors for pure steatosis in alcoholic patients.
    Naveau S; Thaury J; Barri-Ova N; Balian A; Dauvois B; Njiké-Nakseu M; Prévot S; Agostini H; Perlemuter G
    Alcohol Clin Exp Res; 2009 Jun; 33(6):1104-10. PubMed ID: 19382900
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The liver and the waistline: Fifty years of growth.
    Farrell GC
    J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S105-18. PubMed ID: 19799688
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Non alcoholic fatty liver. A frequent entity with an unknown outcome].
    Barisio D'Angelo MG; Mariel Actis A; Outomuro D
    Rev Gastroenterol Peru; 2009; 29(1):44-50. PubMed ID: 19424408
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The impact of hepatic steatosis on the natural history of chronic hepatitis C infection.
    Cross TJ; Quaglia A; Hughes S; Joshi D; Harrison PM
    J Viral Hepat; 2009 Jul; 16(7):492-9. PubMed ID: 19200134
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of the lipogenic pathway in the development of hepatic steatosis.
    Postic C; Girard J
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):643-8. PubMed ID: 19195625
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Hepatocellular carcinoma--an increasing problem in the Western world].
    Wiedermann KH
    MMW Fortschr Med; 2009 Apr; 151(15):40-3. PubMed ID: 19728682
    [No Abstract]   [Full Text] [Related]  

  • 54. Non-alcoholic fatty liver disease (NAFLD)--the hepatic component of metabolic syndrome.
    Uchil D; Pipalia D; Chawla M; Patel R; Maniar S; Narayani ; Juneja A
    J Assoc Physicians India; 2009 Mar; 57():201-4. PubMed ID: 19588647
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New onset diabetes mellitus after liver transplantation and hepatitis C virus infection: meta-analysis of clinical studies.
    Chen T; Jia H; Li J; Chen X; Zhou H; Tian H
    Transpl Int; 2009 Apr; 22(4):408-15. PubMed ID: 19207185
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Interview: questions to professor Yves Deugnier].
    Deugnier Y
    Gastroenterol Clin Biol; 2003; 27(8-9):814-6. PubMed ID: 14586253
    [No Abstract]   [Full Text] [Related]  

  • 57. Fatigue in non-alcoholic fatty liver disease: is there a role for hypothyroidism.
    Kalaitzakis E
    Gut; 2009 Jan; 58(1):149-50; author reply 150. PubMed ID: 19091838
    [No Abstract]   [Full Text] [Related]  

  • 58. Impact of obesity, steatosis and insulin resistance on progression and response to therapy of hepatitis C.
    Negro F; Clément S
    J Viral Hepat; 2009 Oct; 16(10):681-8. PubMed ID: 19732324
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New onset diabetes: can it be delayed?
    Vasisht KP; Bakris G
    J Hum Hypertens; 2008 Aug; 22(8):517-9. PubMed ID: 18496556
    [No Abstract]   [Full Text] [Related]  

  • 60. Case management in children affected by non-alcoholic fatty liver disease.
    Nobili V; Manco M; Raponi M; Marcellini M
    J Paediatr Child Health; 2007 May; 43(5):414. PubMed ID: 17489837
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.